Facebook Twitter LinkedIn
CIS

CIS

The science and practice of human immunology

The science and practice of human immunology
| MENU |

CIS/Horizon Pharma Fellowship Award

The application is now closed.

The Clinical Immunology Society (CIS) and Horizon Pharma are pleased to announce the Fellowship Award, which offers an award to an individual in the third or fourth year of their fellowship program with a concentration or focus on primary immunodeficiency.  The 2016 Fellowship Award will provide one individual a two-year grant in the amount of $60,000.

The objective of the grant is to support the development of academic clinical immunology research careers of advanced fellows-in-training who have demonstrated commitment to the study of primary immunodeficiency as a career path in the United States. Funding is to support the education and research endeavors of this individual. This award is made possible by a generous unrestricted grant from Horizon Pharma.

Click here for full details of the award, including terms and submission guidelines.

ELIGIBILITY

  • Applicants must hold an MD, DO or MD/PhD degree and plan to pursue a career in primary immunodeficiency;
  • Applicants must be a third year fellow-in-training at the start of funding, with a concentration or focus on primary immunodeficiency and be in good standing within the program;
  • Applicants must be enrolled in one of the recognized specialty boards in the US (i.e. allergy, immunology, hematology, infectious diseases, etc.)

CONDITIONS OF THE AWARD:

  • The award is $60,000 for two years.
  • Award begins July 1, 2016 and ends June 30, 2018.
  • Funds may be used for any combination of salary and/or lab support.
  • Award may only be used for direct costs. Institutional indirect or general overhead costs cannot be covered.
  • During the period of this award, the recipient may not accept other grants or other external funds of more than $15,000 that provide stipend or salary support for the same work outlined in the application.
  • Recipient must make proper acknowledgements in presentations and publications resulting from the research sponsored by the award. Awardee will also notify the Grant Committee of any publications resulting from the work supported by the Fellowship Award.
  • The institution is responsible for documenting its role in terms of supporting the education and research efforts as well as providing adequate research capacity, including space and equipment, for the award recipient.
  • The recipient must submit a final written progress report to the CIS at the conclusion of the award period. It is also expected the recipient will present the final results of their research at a future CIS Meeting.
  • Awardee’s institution is required to submit a financial progress report at the conclusion of the award period.
  • CIS may discontinue an award if it is documented that the purpose or the terms of the award are not being fulfilled. In this event, the recipient will be notified in writing of this determination, the reason, and the effective date.

Click here for full details of the award, including terms and submission guidelines.

The application deadline was December 11, 2015.